Kathy Lee-Sepsick, CEO Femasys “Advancing Women’s Healthcare with Innovative Medical Devices” at the SEMDA Conference 2012
Founded in 2004 and headquartered in Georgia, Femasys remains a privately held corporation committed to advancing women’s healthcare with innovative medical devices designed exclusively for use in the physician’s office. Femasys is led by an experienced management team with over 160 years of collective industry experience with extensive focus in medical devices. SNNLive spoke with Kathy Lee-Sepsick, President and CEO of Femasys at the Southeastern Medical Device Association (SEMDA) Conference 2012 in Atlanta, GA.
“I founded the company in 2004 with an overwhelming desire to advance women’s healthcare. We bring to market innovative medical devices. Our first product, Femvue, is on the market globally. We are using distributors to commercialize our product today”, Mr. Lee-Sepsick begins. She goes on to discuss what Femvue does: ”Femvue is an infertility diagnostic test that brings a radiology test into the ObGyn’s office. We use existing ultrasound and we’re able to evaluate a women’s fallopian tubes as part of her infertility assessment.”
“I have 4 in the pipeline. One that’s on the market, one that were about ready to commercialize. Another that’s going to come through the FDA 510-K pathway this year. And, one that is class 3 PMA device that is still in development”, she concludes. For more information about Femasys, check out their website. SNNLive welcomes Kathy Lee-Sepsick, CEO of Femasys.
Micro-Cap Review Latest Issue
Cavaet Emptor or Buyer Beware by SNN Inc. CEO Sheldon “Shelly” Kraft
Check out the book "Caveat Emptor" written by CEO Sheldon Kraft, click on the image to view a preview and the full book can be purchased for $15.95.
There are some best practices and good hints on what to look out for in today’s volatile markets.